1.Experimental study on systemic hematogenic immunoreactions activated by bacteria in simulation of natural system
Feng GUO ; Le-Zhi ZHANG ; Pin-E GUO ; Yu-Lian XU ; Mei-Xian HUA ; Bao-Hua QIAN ;
Chinese Journal of Infectious Diseases 2007;0(11):-
Objective To study systemic hematogenic immunoreactions induced by bacterial infections using simulation of natural system.Methods Whole blood 0.2 mL or white blood cells 0.2 mL and plasma(or normal saline)0.3 mL were stimulated by 0.2 mL of yeast and inactivated Bacillus Calmette-Guerin(BCG,5?10~8/mL),respectively,which were incubated at 37℃for 1 h. Interleukin(IL)-8,C3,C4 and chemokine receptor Fy6 were detected by flow cytometry(FCM)and en- zyme-linked immunosorbentassay(ELISA).Results Bacteria could activate red blood cell to modulate IL-8 release from white blood cells in plasma.In nature experimental group,activation rate(37.04?34.84)of IL-8 was significantly higher than that(1.09?0.77)in isolation experimental group.In nature experimen- tal group,value increment(0.01?0.01)of complement C4 was significantly higher than that(-0.0027?0.008)of isolation experimental group(P
2.Imatinib Combined with VP Low Dose Regiment for Treating Newly Diagnosed Adult Patients with Ph-positive ALL.
Kui LIU ; Yue-Lu GUO ; Zi-Long YAO ; Xiang-Shu JIN ; Ran ZHANG ; Xiao-Pin HAN ; Xiao-Ning GAO ; Li YU ; Yu JING
Journal of Experimental Hematology 2015;23(6):1560-1563
OBJECTIVETo investigate the inductive therapeutic effects of imatinib combined with VP low dose regiment on adult patients with Ph-positive acute lymphoblastic leukemia (Ph(+) ALL).
METHODSFourteen newly diagnosed adult patients with Ph(+) ALL were treated with VP regimen, and imatinib (400 mg/d) was added at the 8(th) day. VP regimen would be stopped when neutropenia lasted for 1 week or complicated with infection, fever, etc. Therapeutic effects were assessed by bone marrow morphology and quantitative analysis of BCR/ABL:ABL at the 28(th) - 33(rd) day. Patients could be treated with imatinib combined with chemotherapy for consolidation and maintenance therapy or were treated with allogeneic hematopoietic stem cell transplantation after complete remission.
RESULTSFourteen cases obtained CR1 after first course of treatment, the median decline of BCR/ABA:ABL was 55.89 (10.25 -180.97) %; during the induction chemotherapy, pulmonary infection occurred in 3 patients, diarrhea in 1 patients, facial edema in 3 patients, however, all these patients were cured after symptomatic treatment, only 1 patient died of relapse after transplantation.
CONCLUSIONIn the period of tyrosine kinase inhibitor (TKI), inductive chemotherapy combined with imatinib and low dose VP can obtaine satisfactory CR rate and decrease the toxicity of the traditional drugs. It is suggested that TKI combined with VP regimen chemotherapy can achieve CR1 and make possible for allo-HSCT, from which patients can achieve the long-term survival.
Adult ; Antineoplastic Combined Chemotherapy Protocols ; Bone Marrow ; Cisplatin ; Fusion Proteins, bcr-abl ; Hematopoietic Stem Cell Transplantation ; Humans ; Imatinib Mesylate ; Induction Chemotherapy ; Neutropenia ; Precursor Cell Lymphoblastic Leukemia-Lymphoma ; Protein Kinase Inhibitors ; Recurrence ; Remission Induction ; Transplantation, Homologous ; Vindesine
3.In vitro effects of Genkwa Flos chloroform extract on activity of human liver microsomes UGTs and UGT1A1.
Ning CHEN ; Pei-Pei MIAO ; Chang-E GUO ; Hong-Ying CHEN ; Peng-Kai MA ; Hong-Pin LI ; Hong-Yu ZHU ; Xing GAO ; Yu-Jie ZHANG
China Journal of Chinese Materia Medica 2016;41(17):3296-3302
To predict the mechanism of liver injury induced by Genkwa Flos, we investigated the effect of chloroform extract on UGTs and UGT1A1 activities of the liver microsomes in rat and human. In the present study, 4-nitrophenol(4-NP) and β-estradiol were elected as substrates to determine activities of UGTs and UGT1A1 by UV and HPLC. The results showed that there were 1.00% of apigenin, 6.40% of hydroxygenkwanin and 18.38% of genkwanin in chloroform extract; and total diterpene mass fraction was 31.40%. Compared with the control group, chloroform extract could significantly inhibit the activity of UGTs in rat liver microsomes(RLM) system, while the inhibitory effect was not obvious in human liver microsomes(HLM) system. UGT1A1 activity was inhibited by chloroform extract in rat liver microsomes and human liver microsomes (based on genkwanin, IC₅₀=8.76, 10.36 μmol•L⁻¹). The inhibition types were non-competitive inhibition(RLM) and uncompetitive inhibition(HLM). In conclusion, the results indicated that chloroform extract showed different inhibitory effects on UGTs and UGT1A1 activity, which may be one of the mechanisms of liver injury induced by Genkwa Flos.
4.Second-generation Sequencing Analysis of Ph
Xin LIAO ; Pin-Li ZOU ; Ya-Li SHEN ; Yu-Xia GUO ; Lin SONG ; Jian-Wen XIA
Journal of Experimental Hematology 2021;29(4):1101-1108
OBJECTIVE:
To screen the core genes of Philadelphia chromosome positive/Ph like T-cell acute lymphoblastic leukemia (Ph
METHODS:
The WES/RNA-seq examination results of Ph
RESULTS:
For Ph
CONCLUSION
There are obviously abnormal DNA damage repair pathways in children with Ph
Child
;
Computational Biology
;
Gene Expression Profiling
;
Gene Expression Regulation, Neoplastic
;
Humans
;
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/genetics*
;
Signal Transduction
;
Software